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Yang et al., at the Department of Chemistry, University of Hong Kong and Sun Yat-sen University have characterized a series of bismuth 
citrate complexes by X-ray crystallography and modeled the structure of ranitidine bismuth citrate, a medicine used widely for the treat-
ment of peptic ulcer and gastric reflux disease. The polymeric framework of bismuth citrate may serve as a “drug carrier” for delivery of 
other drugs in the human body. This significant contribution was reported in SCIENCE CHINA Chemistry 2010, 53(10). 
Elements that possess anti-bacterial activity have significant medical applications. Bismuth, the heaviest stable element in the periodic 
table, exhibits anti-bacterial activity against Helicobacter pylori with minimal toxicity. It is used widely to treat peptic ulcers and gastroin-
testinal diseases. Ranitidine bismuth citrate (RBC) is a bismuth citrate-based (Bi(cit)-based) drug, developed in 1991. It exhibits efficacy in 
first-, second- and third-line H. pylori infection therapies when used in combination with other antibiotics, and is more effective than proton 
pump inhibitor-based (PPI-based) therapy. Because of the importance of Bi(cit)-based drugs, enormous efforts have been made to elucidate 
their structures. However, there are few structures that reflect the nature of Bi(cit)-based drugs in the stomach. 
In this work, the frameworks of four Bi(cit)-based complexes, obtained under acidic conditions to mimic conditions in the stomach, were 
resolved. A structural model of RBC was proposed based on the crystal structure of one of these frameworks. The decomposition behavior 
of Bi(cit)-based complexes in aqueous solution was investigated using ESI-MS. 
Bi(cit)-based complexes form polymeric porous frameworks with bismuth citrate dimeric units ([Bi(cit)2Bi]
2–) forming the skeleton. 
Since citrate anions in the frameworks are present in the fully deprotonated, tetraanionic form ([C6H4O7]4–), and coordinate with Bi3+ 
cations, the excess negative charges in these polyanionic frameworks must be balanced by further cations such as K+, [NH4]+, 
[H3NCH2CH2NH3]
2+ or [C5H6N]
+. This allows Bi(cit)-based complexes to encapsulate low-molecular mass molecules or ions, either by a 
diffusion process or via electrostatic interactions, similar to the “uptake process” of cations and small molecules by zeolites. Ranitidine 
cations were modeled into a simulated structure based on one experimental framework, revealing hydrogen-bond formation between raniti-
dine molecules and the citrate tetraanions. ESI-MS data indicated that the Bi(cit)-based frameworks degrade from high molecular weight 
polymers to low molecular weight species in acidic solution. 
This paper reports a series of structures of Bi(cit)-based complexes in acidic solution (mimicking the acidic environment of the stomach), 
establishes an in silico model of a widely used anti-ulcer drug (ranitidine bismuth citrate), and uses experimental ESI-MS data to propose a 
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